-+ 0.00%
-+ 0.00%
-+ 0.00%

IMUNON - IMNN-001 UNDER EVALUATION IN PHASE 3 OVATION 3 TRIAL FOR ADVANCED OVARIAN CANCER

Reuters·07/21/2026 13:00:05

Please log in to view news